Loan Agreement with the Brabant Startup Fund

NC Biomatrix b.v. located in Eindhoven, Netherlands signed a significant loan agreement with the Brabant Startup Fund BV located in Tilburg, Netherlands to fund key preclinical tasks for the company‚Äôs unique biomatrix technology. NC Biomatrix, established by NLC and the TU/e develops resorbable acellular injectable biomatrices to address millions of patients suffering from back pain […]

NC Biomatrix presents at the EIT investor lounge in Delft

NC Biomatrix presents at the EIT investor lounge in Delft. After becoming a member of the EIT Health network, NC Biomatrix was selected as one of 3 companies to present to a select group of European investors at the EIT investor lounge in Delft. CEO Bob Guilleaume commented “We really appreciate the support of the […]

NC Biomatrix receives Boost4Health voucher

NC Biomatrix receives Boost4Health voucher to support their biomechanical testing of the innovative injectable biomatrix technology to treat patients with back pain due to disc degeneration. NC Biomatrix CSO Prof. Keita Ito states “We appreciate the support by the Brabant region for our collaboration with the Biomechanical Testing Institute at the University of Ulm, Germany. […]

NC Biomatrix awarded MIT Feasability Grant

NC Biomatrix awarded MIT Feasibility Grant. NC Biomatrix was awarded an MIT Feasibility grant to initiate validation of their injectable biomatrix technology to treat patients with back pain due to disc degeneration. NC Biomatrix CEO Bob Guilleaume commented “We are very grateful for the support by the MIT program. This grant will allow us to […]